With more than 9.33 million shares outstanding, Pharmedic will need to spend more than VND36 billion to pay dividends to shareholders.
In 2024, Pharmedic adjusted its dividend payment plan from 24% to 62.68%. Previously, the company made two dividend payments with a total rate of 24%. Thus, after the final payment, the company will complete its dividend payment obligation for 2024.
Right before Pharmedic announced its dividend payment plan, on August 15, Saigon - Hanoi Securities Corporation (stock code: SHS) successfully sold all of its more than 1.36 million PMC shares (equivalent to 14.6% of shares) through negotiation, in order to restructure its investment portfolio, thereby no longer being a shareholder here.
Regarding Pharmedic's business situation, according to the audited semi-annual business report, in the first half of 2025, the Company's revenue reached nearly 258 billion VND, an increase of 8% over the same period.
The reason is that PMC has promoted promotional programs to thank customers and take advantage of available domestic raw materials to reduce costs.
Cost of goods sold decreased slightly, gross profit increased from nearly 86 billion to 111.2 billion VND. Deducting cost of goods sold and expenses, PMC reported a profit after tax of 45 billion VND, an increase of more than 16% over the same period last year.
In 2025, Pharmedic targets revenue of VND539 billion, up 8% compared to 2024, but pre-tax profit is expected to decrease slightly by 3% to VND97 billion. The company said that profit decreased because the company has returned the development investment fund and distributed dividends in 2 consecutive years 2023 and 2024.
With pre-tax profit for 6 months reaching 56.4 billion VND, the Company has completed 58% of the annual profit target.
Source: https://baovanhoa.vn/kinh-te/pmc-sap-tra-co-tuc-bang-tien-ti-le-3868-165847.html
Comment (0)